Standout Papers
Citation Impact
Citing Papers
Human Hypertension Caused by Mutations in WNK Kinases
2001 StandoutScience
K + Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary Hypertension
2011 Science
Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
2008 Standout
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
Trastuzumab emtansine (T-DM1) renders HER2 + breast cancer highly susceptible to CTLA-4/PD-1 blockade
2015
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
2012 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Finishing the euchromatic sequence of the human genome
2004 StandoutNature
Primary aldosteronism: from genesis to genetics
2003
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Molecular genetics of human hypertension
1998
Primary aldosteronism—careful investigation is essential and rewarding
2003
Glucocorticoid-Remediable Aldosteronism
2003
A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22)
2000
Ribosome-inactivating proteins from plants
1993
Clinical and molecular aspects of adrenocortical tumourigenesis
2003
Hypertension caused by a truncated epithelial sodium channel γ subunit: genetic heterogeneity of Liddle syndrome
1995
Laboratory challenges in primary aldosteronism screening and diagnosis
2015
Liddle's syndrome: Heritable human hypertension caused by mutations in the β subunit of the epithelial sodium channel
1994
Molecular Mechanisms of Human Hypertension
2001 Standout
Glucocorticoid-remediable Aldosteronism
2011
Cushing's syndrome
2015 Standout
Phaeochromocytoma
2005 Standout
Molecular basis of human hypertension: Role of angiotensinogen
1992 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Evidence for Abnormal Left Ventricular Structure and Function in Normotensive Individuals with Familial Hyperaldosteronism Type I
2005
Glucocorticoid-remediable aldosteronism is associated with severe hypertension in early childhood
2001
Molecular basis of the Cd36 chromosomal deletion underlying SHR defects in insulin action and fatty acid metabolism
2002
Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneity
2005
Vaccines: past, present and future
2005
Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction
1992 StandoutNature
Complementation of reduced survival, hypotension, and renal abnormalities in angiotensinogen-deficient mice by the human renin and human angiotensinogen genes.
1997 StandoutNobel
Primary Hyperaldosteronism in Essential Hypertensives: Prevalence, Biochemical Profile, and Molecular Biology1
2000
Microarray, qPCR, andKCNJ5Sequencing of Aldosterone-Producing Adenomas Reveal Differences in Genotype and Phenotype between Zona Glomerulosa- and Zona Fasciculata-Like Tumors
2012
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
2015 Standout
Primary aldosteronism
1995
Severe autosomal dominant hypertension and brachydactyly in a unique Turkish kindred maps to human chromosome 12
1996
Mineralocorticoid hypertension
1994
CD36 is a sensor of diacylglycerides
2005 StandoutNatureNobel
TRP channels as cellular sensors
2003 StandoutNature
Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system
2005 StandoutNobel
Liddle's Syndrome Revisited -- A Disorder of Sodium Reabsorption in the Distal Tubule
1994
A Human Challenge Model for Mycobacterium tuberculosis Using Mycobacterium bovis Bacille Calmette-Guérin
2012
A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro.
1997
A Novel Form of Human Mendelian Hypertension Featuring Nonglucocorticoid-Remediable Aldosteronism
2008
Male–female differences in fertility and blood pressure in ACE-deficient mice
1995 StandoutNatureNobel
Cancer immunotherapy comes of age
2011 StandoutNature
Liddle’s Syndrome
1998
Familial hyperaldosteronism
2001
Somatic Inactivation of Pkd2 Results in Polycystic Kidney Disease
1998
Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase
1992
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
Homeostasis in Mice with Genetically Decreased Angiotensinogen Is Primarily by an Increased Number of Renin-producing Cells
1999 StandoutNobel
Cushing's syndrome
2006 Standout
Atherosclerosis
2000 StandoutNature
Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension
1992
Trastuzumab-DM1 (T-DM1) retains all the mechanisms of action of trastuzumab and efficiently inhibits growth of lapatinib insensitive breast cancer
2010
Rictor/TORC2 regulates fat metabolism, feeding, growth, and life span in Caenorhabditis elegans
2009 StandoutNobel
Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na–K–2CI cotransporter NKCC2
1996
Human hypertension caused by mutations in the kidney isozyme of 11β–hydroxysteroid dehydrogenase
1995
HIGH INCIDENCE OF PRIMARY ALDOSTERONISM IN 199 PATIENTS REFERRED WITH HYPERTENSION
1994
Genome Duplications and Other Features in 12 Mb of DNA Sequence from Human Chromosome 16p and 16q
1999
A gene differentially expressed in the kidney of the spontaneously hypertensive rat cosegregates with increased blood pressure.
1993
Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene.
1993 StandoutNobel
Molecular Genetics of Human Blood Pressure Variation
1996 Science
Fibrosis, not cell size, delineates β-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo
2006 StandoutNobel
Genetic Models of Human Vascular Disease
1995 StandoutNobel
Adrenomedullin gene expression differences in mice do not affect blood pressure but modulate hypertension-induced pathology in males
2007 StandoutNobel
Estrogen receptor variant and hypertension in women.
1993
Correction of factor IX deficiency in mice by embryonic stem cells differentiated in vitro
2005 StandoutNobel
Abnormal Vascular Function and Hypertension in Mice Deficient in Estrogen Receptor β
2002 StandoutScienceNobel
Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor
2004 StandoutNobel
Phase II Study of the Antibody Drug Conjugate Trastuzumab-DM1 for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2) –Positive Breast Cancer After Prior HER2-Directed Therapy
2010
Cardiac hypertrophy and sudden death in mice with a genetically clamped renin transgene
2004 StandoutNobel
Genetic Analysis of Inherited Hypertension in the Rat
2000
Intracranial Aneurysm and Hemorrhagic Stroke in Glucocorticoid-remediable Aldosteronism
1998
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
2011 Standout
A genetically clamped renin transgene for the induction of hypertension
2002 StandoutNobel
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
2016 Standout
Natriuretic peptide receptor 1 expression influences blood pressures of mice in a dose-dependent manner
1998 StandoutNobel
Genetic Dissection of Complex Traits
1994 StandoutScience
Seven Lessons From Two Candidate Genes in Human Essential Hypertension
1999
Regulation and Physiological Roles of Serum- and Glucocorticoid-Induced Protein Kinase Isoforms
2001
Gene Targeting Approaches to Analyzing Hypertension
1999 StandoutNobel
Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugate
2008
Genetic control of blood pressure and the angiotensinogen locus.
1995 StandoutNobel
Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury
2007 StandoutNobel
Measurement of Peripheral Plasma 18-Oxocortisol Can Discriminate Unilateral Adenoma From Bilateral Diseases in Patients With Primary Aldosteronism
2015
Targeted gene duplication and disruption for analyzing quantitative genetic traits in mice.
1994 StandoutNobel
Minireview: Primary Aldosteronism—Changing Concepts in Diagnosis and Treatment
2003
Uncompensated polyuria in a mouse model of Bartter's syndrome
2000 StandoutNobel
The Clinically Inapparent Adrenal Mass: Update in Diagnosis and Management
2004
Ectopic and Abnormal Hormone Receptors in Adrenal Cushing’s Syndrome*
2001
Gene targeting approaches to complex genetic diseases: atherosclerosis and essential hypertension.
1995 StandoutNobel
Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes
2012 Standout
Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system
2005 StandoutNobel
Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5
2012
Engineering Chemical Reactivity on Cell Surfaces Through Oligosaccharide Biosynthesis
1997 StandoutScienceNobel
Reduced growth, abnormal kidney structure, and type 2 (AT 2 ) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT 1A and AT 1B receptors for angiotensin II
1998 StandoutNobel
Genetic Study of Patients with Dexamethasone-Suppressible Aldosteronism without the Chimeric CYP11B1/CYP11B2 Gene
2001
Molecular phenotyping for analyzing subtle genetic effects in mice: Application to an angiotensinogen gene titration
2002 StandoutNobel
Works of Sandra Cook being referenced
Glucocorticoid-remediable Aldosteronism in a Large Kindred: Clinical Spectrum and Diagnosis Using a Characteristic Biochemical Phenotype
1992
In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. IV. Cytotoxic effect of an anti-T11-gelonin immunotoxin.
1988
Clinical Reactogenicity of Intradermal Bacille Calmette‐Guérin Vaccination
1999
A chimaeric llβ-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension
1992 StandoutNature
Immunoconjugates containing novel maytansinoids: promising anticancer drugs.
1992